CLINICAL_TRIALS
trial_result
· 2023-09-07
Clinical Trial Update: A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials [Phase 2]
Summary
Phase 2 long-term extension trial in participants with atopic dermatitis; the study was terminated with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Evelo Biosciences, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: TERMINATED | Results posted: 2023-09-07